中欧中证港股通创新药指数发起A(021759) |
净值:
1.6997
|
日增长率:
0.97%
|
累计净值:1.6997 | 2025-07-18 |
|
股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
01801 | 信达生物 | 576,000.00 | 41,184,000.00 | 9.34 |
02269 | 药明生物 | 1,751,000.00 | 40,955,890.00 | 9.29 |
06160 | 百济神州 | 280,400.00 | 37,795,116.00 | 8.57 |
09926 | 康方生物 | 391,000.00 | 32,785,350.00 | 7.43 |
01093 | 石药集团 | 4,386,000.00 | 30,789,720.00 | 6.98 |
01177 | 中国生物制药 | 6,134,000.00 | 29,443,200.00 | 6.68 |
01530 | 三生制药 | 1,042,500.00 | 22,486,725.00 | 5.10 |
03692 | 翰森制药 | 648,000.00 | 17,580,240.00 | 3.99 |
02359 | 药明康德 | 210,600.00 | 15,104,232.00 | 3.42 |
09688 | 再鼎医药 | 600,300.00 | 15,025,509.00 | 3.41 |
报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
2025-06-30 | 94.38 | - | 16.51 | 441,091,239.26 |
2025-03-31 | 94.42 | - | 14.00 | 73,107,137.85 |
2024-12-31 | 93.34 | - | 8.13 | 29,225,687.78 |